COPENHAGEN, Jan 5 () - Denmark's Novo Nordisk will offer its 1.5 ​and 4 milligram Wegovy weightloss pills ‌at $149 per month ...

Jan 9 () - Amazon Pharmacy said on Friday it now offers Novo Nordisk's Wegovy weight-loss pill through insurance plans as ...

(Bloomberg) -- A rebound in Denmark’s pharmaceutical industry, dominated by Novo Nordisk A/S, powered the economy to its fastest quarterly expansion in almost four years. Gross domestic product rose 2 ...

Weaker prospects for pharmaceutical giant Novo Nordisk A/S (NYSE:NVS) have prompted Denmark's economic ministry to cut its 2025 GDP forecast, now expecting just 1.4% growth, down 1.5 percentage points ...

Thankfully, 2026 could be a much better year for the Denmark-based drugmaker. Let's consider two tailwinds that could help ...

COPENHAGEN, Dec 4 (Reuters) - Denmark on Thursday sharply raised its economic growth forecast for 2025, due in part to the pharmaceuticals industry, which is performing well, its economy minister said ...

LONDON/COPENHAGEN, Oct 15 (Reuters) - Romel Amineh is one of a fast-growing group of Novo Nordisk workers in Denmark laid off as the drugmaker battles to cut costs and revive its fortunes in a ...

Novo Nordisk (NYSE: NVO) was once the top player in the weight loss drug market. The company's medicine, Wegovy, practically ...

FRANKFURT, Germany — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the ...

The general mood among these heavyweight investors is divided, with 35% leaning bullish and 37% bearish. Among these notable options, 12 are puts, totaling $1,065,123, and 33 are calls, amounting to ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Today, the Supreme People’s Court in China made a positive decision concerning the intellectual property rights relating to the semaglutide compound patent. Novo Nordisk is pleased that the Court has ...